Cargando…
Macrophages in Chronic Liver Failure: Diversity, Plasticity and Therapeutic Targeting
Chronic liver injury results in immune-driven progressive fibrosis, with risk of cirrhosis development and impact on morbidity and mortality. Persistent liver cell damage and death causes immune cell activation and inflammation. Patients with advanced cirrhosis additionally experience pathological b...
Autores principales: | Singanayagam, Arjuna, Triantafyllou, Evangelos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051585/ https://www.ncbi.nlm.nih.gov/pubmed/33868313 http://dx.doi.org/10.3389/fimmu.2021.661182 |
Ejemplares similares
-
The Role of Monocytes and Macrophages in Acute and Acute-on-Chronic Liver Failure
por: Triantafyllou, Evangelos, et al.
Publicado: (2018) -
Lipids in Liver Failure Syndromes: A Focus on Eicosanoids, Specialized Pro-Resolving Lipid Mediators and Lysophospholipids
por: Artru, Florent, et al.
Publicado: (2022) -
Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases
por: van der Heide, Daphne, et al.
Publicado: (2019) -
CD14(+) CD15(−) HLA-DR(−) myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure
por: Bernsmeier, Christine, et al.
Publicado: (2018) -
Abnormal Innate Immunity in Acute-on-Chronic Liver Failure: Immunotargets for Therapeutics
por: Khanam, Arshi, et al.
Publicado: (2020)